Clinical trial

A Study of PM8002 in Combination With Chemotherapy in Patients With SCLC

NCT05879068

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2022-05-27

PhasePHASE2

Study timeline

Study start (actual)2022-05-27Date precision: day

Registry last updated2024-12-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

SCLCunresolved

Interventions

PM8002DRUG

PaclitaxelDRUG · verified · RxNorm: paclitaxel

Sponsors & collaborators

Biotheus Inc.lead sponsor

Mapped research locations

BeijingChina1 ShanghaiChina1 ChengduChina1 HangzhouChina1 ChangshaChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05879068 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.